Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaborators
Dominik Denschlag*, Florian Heitz, Jacobus Pfisterer, Darja Tutschkow, Alexander Reuss, Werner Meier, Philipp Harter, Pauline Wimberger, Mansoor Raza Mirza, Isabelle Ray-Coquard, Giovanni Scambia, Jae-Weon Kim, Nicoletta Colombo, Ana Oaknin, Jalid Sehouli, Kristina Lindemann, Coriolan Lebreton, Michael Eichbaum, Stefan Spiegelberg, Hannah WoopenAndreas du Bois
Dive into the research topics of 'Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaborators'. Together they form a unique fingerprint.